Double localisation secondaire cutanée et sinusienne révélant un adénocarcinome à cellules claires du rein: un cas avec revue de la littérature

Situé au troisième rang des cancers urologiques, le cancer du rein métastase habituellement au niveau du poumon, des os et du foie. Nous rapportons ici le cas clinique de métastases cutanée et sinusienne ayant révélées un cancer du rein chez un sujet de sexe masculin âgé de 70 ans

Genetic diversity of Plasmodium falciparum infection among children with uncomplicated malaria living in Pointe-Noire, Republic of Congo

Introduction: molecular characterization of malaria parasites from different localities is important to improve understanding of acquisition of natural immunity to Plasmodium falciparum, to assist in identifying the most appropriate strategies for control and to evaluate the impact of control interventions. This study aimed to determine the genetic diversity and the multiplicity of infection in Plasmodium falciparum isolates from Pointe-Noire, Republic of Congo. Methods: Plasmodium falciparum isolates were collected from 71 children with uncomplicated malaria; enrolled into the study for evaluating the therapeutic efficacy of artemether-lumefantrine combination. Both msp-1 and msp-2 genes were genotyped. Results: from 296 distinct fragments detected, 13 msp-1 and 27 msp-2 different alleles were identified. For msp-1, RO33 family was poorly polymorphic. The K1 family has shown the trend of predominance (41%), followed by Mad20 (35%). Comparatively to msp-2, 49.6% and 48.8% fragments belonged to 3D7 and FC27 respectively. Taking together msp-1 and msp-2 genes, the overall multiplicity of infection has been increased to 2.64 and 86% harbored more than one parasite genotype. Parasite density was not influenced by age as well as the multiplicity of infection which was not influenced neither by age nor by parasite density. Conclusion: genetic diversity of Plasmodium falciparum in isolates from patients with uncomplicated malaria in Pointe-Noire is high and consisted mainly of multiple clones. The overall multiplicity of infection has been largely increased when considering msp-1 and msp-2 genes together. With the changes in malaria epidemiology, the use of both msp-1 and msp-2 genes in the characterization of Plasmodium falciparum infection is recommended

Genetic polymorphism of merozoite surface protein 2 and prevalence of K76T pfcrt mutation in Plasmodium falciparum field isolates from Congolese children with asymptomatic infections

<p>Abstract</p> <p>Background</p> <p>In order to prepare the field site for future interventions, the prevalence of asymptomatic <it>Plasmodium falciparum </it>infection was evaluated in a cohort of children living in Brazzaville. <it>Plasmodium falciparum </it>merozoite surface protein 2 gene (<it>msp</it>2) was used to characterize the genetic diversity and the multiplicity of infection. The prevalence of mutant <it>P. falciparum </it>chloroquine resistance transporter (<it>pfcrt</it>) allele in isolates was also determined.</p> <p>Methods</p> <p>Between April and June 2010, 313 children below 10 years of age enrolled in the cohort for malaria surveillance were screened for <it>P. falciparum </it>infection using microscopy and polymerase chain reaction (PCR). The children were selected on the basis of being asymptomatic. <it>Plasmodium falciparum msp2 </it>gene was genotyped by allele-specific nested PCR and the <it>pfcrt </it>K76T mutation was detected using nested PCR followed by restriction endonuclease digestion.</p> <p>Results</p> <p>The prevalence of asymptomatic <it>P. falciparum </it>infections was 8.6% and 16% by microscopy and by PCR respectively. Allele typing of the <it>msp2 </it>gene detected 55% and 45% of 3D7 and FC27 allelic families respectively. The overall multiplicity of infections (MOI) was 1.3. A positive correlation between parasite density and multiplicity of infection was found. The prevalence of the mutant <it>pfcrt </it>allele (T76) in the isolates was 92%.</p> <p>Conclusion</p> <p>This is the first molecular characterization of <it>P. falciparum </it>field isolates in Congolese children, four years after changing the malaria treatment policy from chloroquine (CQ) to artemisinin-based combination therapy (ACT). The low prevalence of asymptomatic infections and MOI is discussed in the light of similar studies conducted in Central Africa.</p

Plasmocytome cutané secondaire révélant un myélome multiple: à propos d’un cas

Le plasmocytome cutané secondaire métastatique est une prolifération plasmocytaire multiple extramédullaire de localisation cutanée. Son diagnostic repose sur la mise en évidence d'une prolifération plasmocytaire maligne au niveau médullaire et cutané. Son apparition s'associe à un stade avancé du myélome et à un pronostic péjoratif.Pan African Medical Journal 2016; 2

Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies

BACKGROUND: Very few data on anti-malarial efficacy are available from the Democratic Republic of Congo (DRC). DRC changed its anti-malarial treatment policy to amodiaquine (AQ) and artesunate (AS) in 2005. METHODS: The results of two in vivo efficacy studies, which tested AQ and sulphadoxine-pyrimethamine (SP) monotherapies and AS+SP and AS+AQ combinations in Boende (Equatorial province), and AS+SP, AS+AQ and SP in Kabalo (Katanga province), between 2003 and 2004 are presented. The methodology followed the WHO 2003 protocol for assessing the efficacy of anti-malarials in areas of high transmission. RESULTS: Out of 394 included patients in Boende, the failure rates on day 28 after PCR-genotyping adjustment of AS+SP and AS+AQ were estimated as 24.6% [95% CI: 16.6-35.5] and 15.1% [95% CI: 8.6-25.7], respectively. For the monotherapies, failure rates were 35.9% [95% CI: 27.0-46.7] for SP and 18.3% [95% CI: 11.6-28.1] for AQ. Out of 207 patients enrolled in Kabalo, the failure rate on day 28 after PCR-genotyping adjustment was 0 [1-sided 95% CI: 5.8] for AS+SP and AS+AQ [1-sided 95% CI: 6.2]. It was 19.6% [95% CI: 11.4-32.7] for SP monotherapy. CONCLUSION: The finding of varying efficacy of the same combinations at two sites in one country highlights one difficulty of implementing a uniform national treatment policy in a large country. The poor efficacy of AS+AQ in Boende should alert the national programme to foci of resistance and emphasizes the need for systems for the prospective monitoring of treatment efficacy at sentinel sites in the country